ECM
TRDA icon

ExodusPoint Capital Management’s Entrada Therapeutics TRDA Stock Holding History

ExodusPoint Capital Management’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Sell
12,067
-25,363
-68% -$291K ﹤0.01% 1407
2025
Q4 		$385K Buy
+37,430
New +$315K ﹤0.01% 1247
2025
Q3 		– Sell
-15,785
Closed -$106K – 2028
2025
Q2 		$106K Buy
+15,785
New +$127K ﹤0.01% 1353
2025
Q1 		– Sell
-16,453
Closed -$284K – 1993
2024
Q4 		$284K Buy
16,453
+1,113
+7% +$20.2K ﹤0.01% 1292
2024
Q3 		$245K Sell
15,340
-184
-1% -$2.9K ﹤0.01% 1415
2024
Q2 		$221K Buy
+15,524
New +$221K ﹤0.01% 1381

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return